• 1.3k views

Tuberculosis Management

Tuberculosis (TB) management involves a comprehensive approach, from diagnosis to treatment, aimed at controlling and curing the infection. Early diagnosis is critical and is often done using sputum tests, chest X-rays, and molecular tests like GeneXpert. Once diagnosed, TB patients are typically treated with a standard regimen of first-line antibiotics, such as isoniazid, rifampicin, pyrazinamide, and ethambutol, over a course of six to nine months. Drug-resistant TB, particularly multidrug-resistant TB (MDR-TB), requires more complex treatment using second-line drugs for longer periods, often up to two years. Adherence to the treatment regimen is crucial, as incomplete treatment can lead to resistance.

About the Speaker

Dr. Deepak Muthreja Profile Image

Dr. Deepak Muthreja

Head of Pulmonary Critical Care, American Oncology Institute, Nagpur

Dr. Deepak Muthreja, a highly skilled pulmonologist, completed his MBBS at Government Medical College, Nagpur, followed by an MD in TB and Chest Diseases at P.D.U. Medical College, Rajkot, and a DNB in Pulmonary Medicine. He also earned European Diplomas in Adult and Pediatric Respiratory Medicine from the University of Bern, Switzerland. With over 2,000 bronchoscopy procedures, 200 thoracoscopies, and the management of more than 10,000 respiratory disease cases, including 1,000 COVID-19 patients, Dr. Muthreja is an expert in both adult and pediatric respiratory care. He also excels in research, hospital operations, and training junior staff.

Upcoming Case Discussions

Leave a Comment

Your email address will not be published.

Author Post

authorimage

Impact

+

Talks

+

webinar

+

no.of registrations

One liner about speaker

Why is speaker relevant?

Dr. Deepak Muthreja's Talks on Assimilate

webinar
Dr. Deepak Muthreja
  • 15th -Oct -2024, TIME : 5:00PM TO 6:00 PM
  • 0

Tuberculosis (TB) management involves a comprehensive approach, from diagnosis to treatment, aimed at controlling and curing the infection. Early diagnosis is critical and is often done using sputum tests, chest X-rays, and molecular tests like GeneXpert. Once diagnosed, TB patients are typically treated with a standard regimen of first-line antibiotics, such as isoniazid, rifampicin, pyrazinamide, and ethambutol, over a course of six to nine months. Drug-resistant TB, particularly multidrug-resistant TB (MDR-TB), requires more complex treatment using second-line drugs for longer periods, often up to two years. Adherence to the treatment regimen is crucial, as incomplete treatment can lead to resistance.

webinar
Dr. Deepak Muthreja
  • 15th -Oct -2024, TIME : 5:00PM TO 6:00 PM
  • 0

Tuberculosis (TB) management involves a comprehensive approach, from diagnosis to treatment, aimed at controlling and curing the infection. Early diagnosis is critical and is often done using sputum tests, chest X-rays, and molecular tests like GeneXpert. Once diagnosed, TB patients are typically treated with a standard regimen of first-line antibiotics, such as isoniazid, rifampicin, pyrazinamide, and ethambutol, over a course of six to nine months. Drug-resistant TB, particularly multidrug-resistant TB (MDR-TB), requires more complex treatment using second-line drugs for longer periods, often up to two years. Adherence to the treatment regimen is crucial, as incomplete treatment can lead to resistance.

webinar
Dr. Deepak Muthreja
  • 15th -Oct -2024, TIME : 5:00PM TO 6:00 PM
  • 0

Tuberculosis (TB) management involves a comprehensive approach, from diagnosis to treatment, aimed at controlling and curing the infection. Early diagnosis is critical and is often done using sputum tests, chest X-rays, and molecular tests like GeneXpert. Once diagnosed, TB patients are typically treated with a standard regimen of first-line antibiotics, such as isoniazid, rifampicin, pyrazinamide, and ethambutol, over a course of six to nine months. Drug-resistant TB, particularly multidrug-resistant TB (MDR-TB), requires more complex treatment using second-line drugs for longer periods, often up to two years. Adherence to the treatment regimen is crucial, as incomplete treatment can lead to resistance.